Izmir Biomedicine and Genome Center (IBG) is the first independent thematic Research Infrastructure in life sciences, located in Izmir, Türkiye. IBG’s main objective is to carry out powerful research on biomedicine and genome sciences, to develop products based on medical and pharmaceutical biotechnologies using its workforce and technical infrastructure, and thus, to contribute to global science and the transformation of national industry.As of 2023, IBG hosts 32 research groups in three main pillars (i) Basic and translational research program, (ii) Technological research program, (iii) Industrial R&D program with a research focus in the fields of cancer, genomics and bioinformatics, stem cells and regeneration, immunology and infectious diseases, neuroscience and bioengineering.
Economic sectors this organisation is active in:
PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES > Scientific research and development
Partnership
This organisation is seeking partnerships of the following nature:
Research Partners
Investment
Strategic Business Partners
Distributors in new markets
Licensing opportunities
Innovations
This organisation has been identified as a Key Innovator for the following EU-funded innovation:
All innovations listed above are ranked by freshness of data, i.e. the innovations most recently analysed by Innovation Radar appear at the top
